SEC EDGAR CompanyFacts fact · reporting period
Gyre Therapeutics, Inc.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$25.062M{"amount": 25062000, "concept": "us-gaap:Revenues", "currency": "USD"}- Entity
- Gyre Therapeutics, Inc.
- Metric
- revenue
- Period
- 2009-01-01 – 2009-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T13:24:35.586422+02:00
Raw response SHA-256
0b63ff21b3f07868412975f32de836af…Official-identifier path
https://factanker.com/fact/sec/cik-0001124105/revenue/2009-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 473000, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001193125-12-099259)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.